Karen L. Smith - 07 May 2021 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Chief Medical Officer
Signature
/s/ S. Scott Lieberman, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
07 May 2021
Net transactions value
-$18,559
Form type
4
Filing time
11 May 2021, 16:30:11 UTC
Next filing
14 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability $18,559 -305 -2.5% $60.85 11,888 07 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes upon vest of restricted stock units granted under the company's stock incentive plan, as amended and restated.